(Reuters) Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management’s nominees. Glass Lewis & Co’s recommendation, released to clients late on Tuesday and seen by Reuters on Wednesday, echoes last week’s report from Institutional Shareholder Services (ISS), which also suggests that shareholders oust the medical equipment and supplies company’s two directors who are up for election this year.
In Natus Proxy Fight, Glass Lewis Supports Voce Nominees
This entry was posted in Syndicated. Bookmark the permalink.
